31.01.2019
- Richard Ridinger, CEO of Basel, Switzerland-based fine chemicals producer Lonza since April 2012, will retire at the end of February and be succeeded on Mar. 1 by Marc Funk...
22.01.2019
- Israel’s tax authority is seeking to recover $271 million in retroactive tax for 2014-2015 from drugmaker Teva, reports said. The newspaper Calcalist said Teva, one of the country...
10.01.2019
- France’s Sanofi is paying $462 million to exit the immuno-oncology pact it established with US biotech Regeneron in 2015 half a year earlier than planned. With the severance...
09.01.2019
- In the latest move by “big pharma” to buy into cancer-focused biotechs, US drugmaker Eli Lilly is acquiring Loxo Oncology for about $8 billion in cash. The plans were announced on...
08.01.2019
- French multinational pharmaceutical company Sanofi is investing €80 million in Germany’s BioNTech. At the same time, the two companies have agreed to extend their research...
07.01.2019
- In the first major pharma deal of the year, Bristol-Myers Squibb (BMS) is to acquire biotech giant Celgene for $74 billion. The cash-and-stock transaction values the US biotech at...
12.12.2018
- Swiss-based Lonza is working with GE Healthcare, a General Electric subsidiary, to establish a biologics facility in Guangzhou, China. The deal will give Lonza a strategic base in...
10.12.2018
- Swiss-based Cilag, an affiliate of Janssen, the pharmaceuticals division of Johnson & Johnson, has entered into a global collaboration and license agreement with biotech company...
07.12.2018
- Evonik has announced plans to “significantly” expand sodium methylate capacity at its site in Mobile, Alabama, USA, to meet rising demand. Upon completion, the plant will be...
05.12.2018
- A new type of cancer treatment developed by a partnership of Bayer with biotech partner Loxo Oncology has won approval from the US Food and Drug Administration (FDA). Vitrakvi is...
